Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-11T02:51:41.021Z Has data issue: false hasContentIssue false
  • English
  • Français

Anchorpoints: an introspective

Published online by Cambridge University Press:  18 September 2015

H.M. Van Praag
Get access Rights & Permissions [Opens in a new window]

Extract

This, then, is what it has been all about. Today I mark the end of an academic career that ranged over 45 years. 1952 was the starting point. In that year, as a medical student, I was accepted as a research assistent by Prof. G.G.J. Rademaker, a neurophysiologist and at the time head of the Department of Neurology at the Academic Hospital in Leiden. The neurological research period was followed by a mycological one. Having received my MD degree and doing my military service, I was asked to carry out a study into the prevalence, prevention and treatment of mycological infections in military personel. For this reason I worked for more than 1, 5 years in Baarn at the section Medical Mycology of the Phytopathological Laboratory, an interacademic institution of the Universities of Amsterdam and Utrecht (1956-1958). Immediately after the military service I became a resident in psychiatry and started – together with the biochemist Prof. B. Leijnse – a research program into the biological determinants of depression. The period of psychiatric investigation lasted until this very day, albeit in different locations, i.e. Rotterdam, Groningen, Utrecht, New York and Maastricht respectively.

Keywords

Academiaaggressionanxietyfamilymental health deliverymonoaminereligionresearchserotonintraining
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 9 , Issue 2 , June 1997 , pp. 38 - 46
Copyright
Copyright © Cambridge University Press 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literature

1.McLanahan, S, Sandefur, G. Growing up with a single Parent. Cambridge, Mass: Harvard Univ Press, 1994.Google Scholar
2.Thompson, AE, Kaplan, CA. Childhood Emotional Abuse. Br J Psychiat 1996; 168: 143–8.CrossRefGoogle ScholarPubMed
3.Van Praag, HM. A critical Investigation of the Significance of Monoamineoxydase Inhibition as a therapeutic Principle in the Treatment of Depression. Utrecht: Thesis, 1962.Google Scholar
4.Feighner, JP, Robins, E, Guze, SB, Woodruff, RA, Winokur, G, Munoz, R. Diagnostic criteria for use in psychiatric research. Arch gen Psychiat 1972; 26: 57–63.CrossRefGoogle ScholarPubMed
5.Spitzer, RL, Endicott, J, Robins, E. Research diagnostic criteria. Arch gen Psychiat 1978; 35: 773–82.CrossRefGoogle ScholarPubMed
6.Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiat 1960; 23: 56–62.CrossRefGoogle ScholarPubMed
7.Van Praag, HM, Uleman, AM, Spitz, JC. The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depression symptom complex. Psychiat Neurol Neurochir 1965; 68: 329–46.Google ScholarPubMed
8.Plutchik, R, Van Praag, HM. Interconvertibility of five self-report measures of depression. Psychiat Res 1987; 22: 243–56.CrossRefGoogle Scholar
9.Plutchik, R, Van Praag, HM, Conte, HR, Picard, S. Correlates of suicide and violence risk. I. The suicide risk measure. Compr Psychiat 1989; 30: 296–302.CrossRefGoogle Scholar
10.Apter, A, Kotier, M, Sevy, S, et al.Correlates of risk of suicide in violent and nonviolent psychiatric patients. Am J Psychiat 1991; 148: 883–7.Google ScholarPubMed
11.Van Praag, HM. About the centrality of mood lowering in mood disorders. Eur Neuropsychopharmacol 1992; 2: 393–402.CrossRefGoogle ScholarPubMed
12.Van Praag, HM. Reconquest of the subjective. Against the waning of psychiatric diagnosing. Br J Psychiat 1992; 160: 266–71.CrossRefGoogle ScholarPubMed
13.Van Praag, HM. Over the mainstream. Diagnostic requirements for biological psychiatric research. Psychiat Res. In press.Google Scholar
14.Van Praag, HM. A transatlantic view of the diagnosis of depression according to the DSM III. I. Controversies and misunderstandings in depression diagnosis. Compr Psychiat 1982; 23: 315–29.CrossRefGoogle Scholar
15.Van Praag, HM. A transatlantic view of the diagnosis of depressions according to the DSM III. II. Did the DSM III solve the problem of depression diagnosis? Compr Psychiat 1982; 23: 330–7.Google Scholar
16.Van Praag, HM, Korf, J, Lakke, JPWF, et al.Dopamine metabolism in depression, psychoses and Parkinson's disease: The problem of the specificity of biological variables in behaviour disorders. Psychol Med 1975; 5: 138–46.CrossRefGoogle Scholar
17.Van Praag, HM, Kahn, RS, Asnis, GM, et al.Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J affect Disord 1987; 13: 1–8.CrossRefGoogle ScholarPubMed
18.Van Praag, HM, Leijnse, B. Neubewertung des Syndroms. Skizze einer funktionellen Pathologie. Psychiat Neurol Neurochir 1965; 68: 50–66.Google Scholar
19.Van Praag, HM, Asnis, GM, Kahn, RS, et al.Monoamines and abnormal behavior. A multi-aminergic perspective. Br J Psychiat 1990; 157: 723–34.CrossRefGoogle Scholar
20.Van Praag, HM. Make Believes in Psychiatry or the Perils of Progress. New York: Brunner Mazel, 1992.Google Scholar
21.Van Praag, HM. Serotonin-related, anxiety/aggression-driven, stressor-pecipitated depression. A psychobiological hypothesis. Eur Psychiat 1996; 11: 57–67.CrossRefGoogle Scholar
22.Van Praag, HM, Korf, J, Puite, J. 5-Hydroxindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 1970; 225: 1259–60.CrossRefGoogle Scholar
23.Van Praag, HM, Korf, J. Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification? Psychopharmacologia 1971; 19: 148–52.CrossRefGoogle Scholar
24.Van Praag, HM, De Haan, S. Central serotonin metabolism and frequency of depression. Psychiat Res 1979; 1: 219–24.CrossRefGoogle ScholarPubMed
25.Van Praag, HM, De Haan, S. Depression vulnerability and 5-hydroxytryptophan prophylaxis. Psychiat Res 1980; 3: 75–83.CrossRefGoogle ScholarPubMed
26.Van Praag, HM, Korf, J, Dois, LCW, et al.A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia 1972;25: 14–21.CrossRefGoogle ScholarPubMed
27.Apter, A, Plutchik, R, Van Praag, HM. Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta psychiat scand 1993; 87: 1–5.CrossRefGoogle ScholarPubMed
28.Åsberg, M, Thoren, P, Träskman, L, et al.‘Serotonin depression’ -a biochemical subgroup within the affective disorders? Science 1976; 191: 478–80.CrossRefGoogle ScholarPubMed
29.Van Praag, HM. Depression, suicide and the metabolism of serotonin in the brain. J affect Disord 1982; 4: 275–90.CrossRefGoogle Scholar
30.Van Praag, HM, Kahn, RS, Asnis, GM, et al.Therapeutic indications for serotonin potentiating compounds. A hypothesis. Biol Psychiat 1987; 22: 205–12.CrossRefGoogle ScholarPubMed
31.Kahn, R, Van Praag, HM, Wetzler, S, et al.Serotonin and anxiety revisited. Biol Psychiat 1988; 23: 189–208.CrossRefGoogle Scholar
32.Van Praag, HM. Faulty cortisol/serotonin interplay. Psychopatho-logical and biological characterisation of a new hypothetical depression subtype (SeCa depression). Psychiat Res 1996;65: 143–57.CrossRefGoogle Scholar
33.Maimon, Moses ben. Thirteen principles of faith. In: Keller, SR, ed. The Jews in Literature and Art. Köln: Könemann Verlagsgesellschaft, 1992.Google Scholar
34.Peli, PH. De Torah Vandaag. Kampen: Kok, 1988.Google Scholar